UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

Familial and Acquired Hemophagocytic Lymphohistiocytosis

Annual review of medicine, 2012-01, Vol.63 (1), p.233-246

Janka, G.E

2012

Volltextzugriff (PDF)

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

Leukemia, 2010-03, Vol.24 (3), p.521-535

2010

Volltextzugriff (PDF)

Co-operative study group for childhood acute lymphoblastic leukemia (COALL) : long-term follow-up of trials 82, 85, 89 and 92

Leukemia, 2000-12, Vol.14 (12), p.2234-2239

2000

Volltextzugriff (PDF)

Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3262-3268

2003

Volltextzugriff (PDF)

Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia

Leukemia, 2006-02, Vol.20 (2), p.264-271

2006

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis

Hematology (Luxembourg), 2005-09, Vol.10 (sup1), p.104-107

Janka, G. E

2005

Volltextzugriff (PDF)

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

Leukemia, 2004-03, Vol.18 (3), p.521-529

2004

Volltextzugriff (PDF)

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome

Leukemia, 2006-03, Vol.20 (3), p.410-416

2006

Volltextzugriff (PDF)

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia

Blood, 2000-08, Vol.96 (3), p.1094-1099

2000

Volltextzugriff (PDF)

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein

Leukemia, 2004-01, Vol.18 (1), p.78-83

2004

Volltextzugriff (PDF)

Relation between genetic variants of the ataxia telangiectasia-mutated ( ) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia

Leukemia, 2005-11, Vol.19 (11), p.1887-1895

2005

Volltextzugriff (PDF)

Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97

Leukemia, 2010-02, Vol.24 (2), p.298-308

2010

Volltextzugriff (PDF)

Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia

Leukemia, 2006-08, Vol.20 (8), p.1377-1384

2006

Volltextzugriff (PDF)

The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)

Haematologica (Roma), 2011-06, Vol.96 (6), p.854-862

2011

Volltextzugriff (PDF)

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia

British journal of cancer, 2003-03, Vol.88 (5), p.775-781

2003

Volltextzugriff (PDF)

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease

Internal medicine journal, 2016-11, Vol.46 (11), p.1347-1348

2016

Volltextzugriff (PDF)

Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia

Leukemia, 1999-12, Vol.13 (12), p.2023-2030

1999

Volltextzugriff (PDF)

Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

British journal of haematology, 1995-12, Vol.91 (4), p.827-833

1995

Volltextzugriff (PDF)

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

Leukemia, 2000-12, Vol.14 (12), p.2193-2194

2000

Volltextzugriff (PDF)

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia

Blood, 2000-10, Vol.96 (8), p.2879-2886

2000

Volltextzugriff (PDF)

Myeloid antigen co‐expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance

British journal of haematology, 1999-06, Vol.105 (4), p.876-882

1999

Volltextzugriff (PDF)

Different expression of glutathione S‐transferase α, μ and π in childhood acute lymphoblastic and myeloid leukaemia

British journal of haematology, 1999-02, Vol.104 (2), p.321-327

1999

Volltextzugriff (PDF)

The modulating effect of PSC 833, cyclosporin a, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia

Leukemia, 1998-06, Vol.12 (6), p.912-920

1998

Volltextzugriff (PDF)

Familial hemophagocytic lymphohistiocytosis

European journal of pediatrics, 1983-09, Vol.140 (3), p.221-230

Janka, G E

1983

Volltextzugriff (PDF)

In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37°C, but not with affinity determined at room temperature

Leukemia, 2002-09, Vol.16 (9), p.1882-1884

2002

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Englisch
(213)
Deutsch
(61)
Japanisch
(36)
Ungarisch
(1)
Spanisch
(1)
Russisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(162)
Science & Technology
(149)
Life Sciences & Biomedicine
(132)
Child
(95)
Female
(82)
Male
(82)
Biological And Medical Sciences
(76)
Medical Sciences
(76)
Hematology
(64)
Child, Preschool
(63)
Infant
(62)
Adolescent
(56)
Oncology
(40)
Adult
(39)
Hematologic And Hematopoietic Diseases
(36)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(35)
Medicin Och Hälsovetenskap
(34)
Pediatrics
(34)
Prognosis
(32)
Pharmacology. Drug Treatments
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Familial and Acquired Hemophagocytic Lymphohistiocytosis

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

Co-operative study group for childhood acute lymphoblastic leukemia (COALL) : long-term follow-up of trials 82, 85, 89 and 92

Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia

Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia

Hemophagocytic lymphohistiocytosis

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein

Relation between genetic variants of the ataxia telangiectasia-mutated ( ) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia

Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97

Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia

The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia

Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease

Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia

Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia

Myeloid antigen co‐expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance

Different expression of glutathione S‐transferase α, μ and π in childhood acute lymphoblastic and myeloid leukaemia

The modulating effect of PSC 833, cyclosporin a, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia

Familial hemophagocytic lymphohistiocytosis

In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37°C, but not with affinity determined at room temperature

Suchergebnisse filtern